乳腺癌脑转移小鼠模型的半脑照射:磁共振成像与组织学评估剂量-反应关系
该研究在乳腺癌脑转移小鼠模型(MDA-MB-231-BR)中实施半脑照射(8、16、24 Gy),采用γ-H2AX免疫组化、纵向MRI及组织学评估肿瘤与正常脑组织的DNA损伤修复及肿瘤反应。结果显示正常脑组织DNA损伤随时间修复而受照肿瘤内残留γ-H2AX磷酸化持续升高,MRI显示受照侧肿瘤生长显著低于未照射侧,组织学显示随剂量增加肿瘤细胞密度显著降低、残留肿瘤细胞核尺寸显著增大。
要点
- 半脑照射后正常脑组织γ-H2AX在11天恢复至背景水平,受照肿瘤内残留γ-H2AX磷酸化仍高于未照射对侧肿瘤。
- MRI显示受照侧肿瘤相对生长显著低于未照射侧,但16 Gy与24 Gy之间MRI肿瘤体积生长无差异。
- 组织学显示随剂量增加肿瘤细胞密度显著降低,残留肿瘤细胞核尺寸随剂量显著增大。
核心结论
- 正常脑实质DNA损伤随时间修复,而受照肿瘤内DNA损伤未修复。
- 存活肿瘤细胞核尺寸存在放射剂量反应,核增大伴DNA损伤未修复提示存活肿瘤细胞继续细胞周期进展并完成DNA复制但胞质分裂失败。
- 半脑照射可有效评估癌细胞系的剂量-反应,为理解脑转移放射抵抗提供实验前提。
研究设计与样本
- 在人乳腺癌(MDA-MB-231-BR)脑转移小鼠模型上使用micro-CT/RT系统进行半脑照射。
- 照射剂量为8、16和24 Gy。
- 在照射后30分钟(急性)和11天(纵向)用γ-H2AX免疫组化定量肿瘤与正常小鼠脑组织的DNA双链断裂。
- 用活体纵向MRI体积评估及组织学肿瘤细胞密度与核尺寸评估肿瘤反应。
主要发现
- 急性期肿瘤γ-H2AX染色在较高剂量饱和,而正常小鼠脑组织H2AX磷酸化继续线性增加。
- 照射后11天脑内γ-H2AX荧光强度恢复至背景水平,受照肿瘤内残留γ-H2AX磷酸化仍高于未照射对侧肿瘤。
- MRI显示受照侧相对肿瘤生长显著低于未照射侧。
- 16 Gy与24 Gy之间MRI肿瘤体积生长无差异,但组织学显示随剂量增加肿瘤细胞密度显著降低。
- 纵向研究中残留肿瘤细胞核尺寸随放射剂量增加显著增大。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brain metastasis is becoming increasingly prevalent in breast cancer due to improved extra-cranial disease control. With emerging availability of modern image-guided radiation platforms, mouse models of brain metastases and small animal magnetic resonance imaging (MRI), we examined brain metastases' responses from radiotherapy in the pre-clinical setting. In this study, we employed half brain irradiation to reduce inter-subject variability in metastases dose-response evaluations. METHODS: Half brain irradiation was performed on a micro-CT/RT system in a human breast cancer (MDA-MB-231-BR) brain metastasis mouse model. Radiation induced DNA double stranded breaks in tumors and normal mouse brain tissue were quantified using γ-H2AX immunohistochemistry at 30 min (acute) and 11 days (longitudinal) after half-brain treatment for doses of 8, 16 and 24 Gy. In addition, tumor responses were assessed volumetrically with in-vivo longitudinal MRI and histologically for tumor cell density and nuclear size. RESULTS: In the acute setting, γ-H2AX staining in tumors saturated at higher doses while normal mouse brain tissue continued to increase linearly in the phosphorylation of H2AX. While γ-H2AX fluorescence intensities returned to the background level in the brain 11 days after treatment, the residual γ-H2AX phosphorylation in the radiated tumors remained elevated compared to un-irradiated contralateral tumors. With radiation, MRI-derived relative tumor growth was significantly reduced compared to the un-irradiated side. While there was no difference in MRI tumor volume growth between 16 and 24 Gy, there was a significant reduction in tumor cell density from histology with increasing dose. In the longitudinal study, nuclear size in the residual tumor cells increased significantly as the radiation dose was increased. CONCLUSIONS: Radiation damages to the DNAs in the normal brain parenchyma are resolved over time, but remain unrepaired in the treated tumors. Furthermore, there is a radiation dose response in nuclear size of surviving tumor cells. Increase in nuclear size together with unrepaired DNA damage indicated that the surviving tumor cells post radiation had continued to progress in the cell cycle with DNA replication, but failed cytokinesis. Half brain irradiation provides efficient evaluation of dose-response for cancer cell lines, a pre-requisite to perform experiments to understand radio-resistance in brain metastases.
引用
- Zarghami N, Murrell DH, Jensen MD, et al. Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response. Radiat Oncol. 2018. PMID: 29859114. doi:10.1186/s13014-018-1028-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。